Citigroup Maintains Neutral on Insulet, Raises Price Target to $172
Insulet Corporation
Insulet Corporation PODD | 0.00 |
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:
PODD) with a Neutral and raises the price target from $165 to $172.
